新型单光子发射计算机断层扫描心肌血流定量示踪剂的临床前与首次人体研究
本研究开发用于SPECT心肌灌注显像与血流测量的新型示踪剂,在鼠和猪中评估三种99mTc标记化合物,筛选出99mTc-4BOH并与99mTc-Teboroxime及99mTc-Sestamibi比较,随后在两个各10例患者的队列中与99mTc-Sestamibi和13N-NH3进行头对头比较,显示99mTc-4BOH心肌摄取高且较稳定,其K1值与13N-NH3 PET心肌血流量显著相关。
要点
- 猪和人中99mTc-4BOH的心肌K1值均显著高于99mTc-Sestamibi(P < .001)。
- 猪中99mTc-4BOH的k2值低于99mTc-Teboroxime,提示较99mTc-Teboroxime更稳定。
- 注射后3–8分钟数据即可获得高质量灌注图像,心肝比值有利、干扰伪影少。
核心结论
- 99mTc-4BOH具有令人鼓舞的药代动力学特征,心肌摄取高且相对稳定,是用于SPECT心肌血流定量的有前景的候选心肌灌注放射性示踪剂。
研究设计与样本
- 研究评估三种99mTc标记化合物(99mTc-4BOH、99mTc-3BOH和99mTc-2BOH),采用小鼠离体分布和猪平面显像研究。
- 99mTc-4BOH被确定为候选化合物,在猪中于碲锌镉SPECT上与99mTc-Teboroxime和99mTc-Sestamibi比较器官摄取和动力学特性。
- 在两个各含10例患者的独立先导队列中,将99mTc-4BOH与99mTc-Sestamibi和13N-NH3进行头对头比较。
主要发现
- 猪静息时99mTc-4BOH的K1值为.81 ± .03 mL/g/min,高于99mTc-Sestamibi的.43 ± .09 mL/g/min(P < .001);猪负荷时1.19 ± .26 mL/g/min vs .50 ± .10 mL/g/min(P < .001)。
- 人静息时99mTc-4BOH的K1值为.74 ± .09 mL/g/min,高于99mTc-Sestamibi的.38 ± .04 mL/g/min(P < .001);人负荷时1.42 ± .17 mL/g/min vs .59 ± .07 mL/g/min(P < .001)。
- 猪静息时99mTc-4BOH的k2值为.18 ± .03/min,低于99mTc-Teboroxime的.26 ± .01/min(P < .001);猪负荷时.26 ± .04/min vs .38 ± .08/min(P < .01)。
- 注射后3–8分钟数据足以产生高质量灌注图像,心肌显示清晰,心肝比值有利使干扰伪影最少。
- 99mTc-4BOH SPECT的K1值与13N-NH3 PET心肌血流量显著相关:患者水平ρ = .83(P < .001),血管水平ρ = .81(P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to develop a dedicated tracer with high first-pass extraction fraction and stable heart retention for single-photon emission computed tomography (SPECT) myocardial perfusion imaging and flow measurement. METHODS: Three 99mTc-labeled compounds (99mTc-4BOH, 99mTc-3BOH, and 99mTc-2BOH) were evaluated by mouse ex vivo distribution and swine planar imaging studies. 99mTc-4BOH was identified as a candidate and compared with 99mTc-Teboroxime and 99mTc-Sestamibi in swine on cadmium zinc telluride SPECT to study organ uptake and kinetic properties. Head-to-head comparisons of 99mTc-4BOH with 99mTc-Sestamibi and 13N-NH3 were performed on two separate pilot cohorts each comprising 10 patients. RESULTS: The myocardial uptake of 99mTc-4BOH demonstrated significantly higher levels than 99mTc-Sestamibi in swine and human, evidenced by higher K1 values (swine rest: .81 ± .03 mL/g/min vs .43 ± .09 mL/g/min, P < .001; stress: 1.19 ± .26 mL/g/min vs .50 ± .10 mL/g/min, P < .001; human rest: .74 ± .09 mL/g/min vs .38 ± .04 mL/g/min, P < .001; stress 1.42 ± .17 mL/g/min vs .59 ± .07 mL/g/min, P < .001). k2 values of 99mTc-4BOH were lower than those of 99mTc-Teboroxime (rest: .18 ± .03/min vs .26 ± .01/min, P < .001; stress: .26 ± .04/min vs .38 ± .08/min, P < .01), suggesting greater stability than 99mTc-Teboroxime in the swine. Three- to 8-min data after injection are sufficient to produce high-quality perfusion images that offer clear visualization of the myocardium and minimal interference artifacts due to favorable heart-to-liver ratios of 99mTc-4BOH. Furthermore, K1 values from 99mTc-4BOH SPECT significantly correlated with 13N-NH3 positron emission tomography myocardial blood flow (MBF) (ρ = .83 on per-patient level, P < .001; ρ = .81 on per-vessel level, P < .001). CONCLUSIONS: 99mTc-4BOH exhibited an encouraging pharmacokinetic profile with high and relatively stable cardiac uptake. It constitutes a promising candidate as myocardial perfusion radiotracer for SPECT MBF quantification.
引用
- Gu Y, Sun R, Ren W, et al. Preclinical and first-in-human studies of a novel tracer for single-photon emission computed tomography myocardial blood flow quantification. J Nucl Cardiol. 2025. PMID: 40675408. doi:10.1016/j.nuclcard.2025.102441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。